Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
See Latest ArticlesBoston Scientific Completes Enrollment in Pivotal Workhorse Trial for Next-Generation Everolimus Stent
Boston Scientific, 09/21/09
Boston Scientific Corporation announced the completion of patient enrollment in the workhorse portion of its PLATINUM clinical program. PLATINUM is a global, randomized, pivotal controlled trial designed to support U.S. Food and Drug Administration and Japanese Ministry of Health, Labor and Welfare approval of the platinum chromium PROMUS Element™ Everolimus–Eluting Coronary Stent System. The trial enrolled 1,532 patients with up to two de novo lesions at more than 140 sites worldwide, and completed enrollment two months ahead of schedule.
Today in Drug Trials...keeping you current
Receive free subspecialty "5-minute updates" via email
Autologous blood therapy for common cold—A randomized, double-blind, placebo-controlled trial
Complementary Therapies in Medicine, 12/08/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Cytokinetics Presents Non-Clinical Data Relating To CK-2017357 At The 5th Cachexia Conference
Cytokinetics, 12/08/09
Sponsor
Article Search
Sponsor